Stress-induced reinstatement of drug seeking: 20 years of progress

JR Mantsch, DA Baker, D Funk, AD Lê… - …, 2016 - nature.com
In human addicts, drug relapse and craving are often provoked by stress. Since 1995, this
clinical scenario has been studied using a rat model of stress-induced reinstatement of drug …

A comprehensive review on the chemical properties, plant sources, pharmacological activities, pharmacokinetic and toxicological characteristics of …

Q Du, X Meng, S Wang - Frontiers in Pharmacology, 2022 - frontiersin.org
Tetrahydropalmatine (THP), a tetrahydroproberine isoquinoline alkaloid, is widely present in
some botanical drugs, such as Stephania epigaea HS Lo (Menispermaceae; Radix …

Role of cues and contexts on drug‐seeking behaviour

CJ Perry, I Zbukvic, JH Kim… - British journal of …, 2014 - Wiley Online Library
Environmental stimuli are powerful mediators of craving and relapse in substance‐abuse
disorders. This review examined how animal models have been used to investigate the …

Novel pharmacotherapeutic treatments for cocaine addiction

D Shorter, TR Kosten - BMC medicine, 2011 - Springer
Cocaine is a stimulant that leads to the rapid accumulation of catecholamines and serotonin
in the brain due to prevention of their re-uptake into the neuron that released the …

Intermittent intake of rapid cocaine injections promotes robust psychomotor sensitization, increased incentive motivation for the drug and mGlu2/3 receptor …

F Allain, DCS Roberts, D Lévesque, AN Samaha - Neuropharmacology, 2017 - Elsevier
The choice between smoking, injecting or swallowing a drug influences the risk of addiction,
as this determines both how much drug gets into the brain and how fast. Most animal studies …

L-Tetrahydropalamatine: A Potential New Medication for the Treatment of Cocaine Addiction

JB Wang, JR Mantsch - Future medicinal chemistry, 2012 - Taylor & Francis
Levo-tetrahydropalmatine (l-THP) is an active constituent of herbal preparations containing
plant species of the genera Stephania and Corydalis and has been approved and used in …

Dopamine D1 and D3 receptor polypharmacology as a potential treatment approach for substance use disorder

E Galaj, S Ewing, R Ranaldi - Neuroscience & Biobehavioral Reviews, 2018 - Elsevier
In the search for efficacious pharmacotherapies to treat cocaine addiction much attention
has been given to agents targeting dopamine D1 or D3 receptors because of the …

5-HT6 receptor antagonists: potential efficacy for the treatment of cognitive impairment in schizophrenia

N MWJ de Bruin, CG Kruse - Current Pharmaceutical Design, 2015 - ingentaconnect.com
5-hydroxytryptamine6 receptor (5-HT6R) antagonists have shown efficacy in animal models
for cognitive impairment in multiple cognitive domains relevant for schizophrenia …

Sustained drug delivery strategies for treatment of common substance use disorders: Promises and challenges

AO Tijani, J Garg, D Frempong, G Verana… - Journal of Controlled …, 2022 - Elsevier
Substance use disorders (SUDs) are a leading cause of death and other ill health effects in
the United States and other countries in the world. Several approaches ranging from …

Discovery of Selective Dopamine Receptor Ligands Derived from (−)-Stepholidine via C-3 Alkoxylation and C-3/C-9 Dialkoxylation

HK Namballa, M Dorogan, AR Gudipally… - Journal of Medicinal …, 2023 - ACS Publications
We evaluated C-3 alkoxylated and C-3/C-9 dialkoxylated (−)-stepholidine analogues to
probe the tolerance at the C-3 and C-9 positions of the tetrahydroprotoberberine (THPB) …